Key Highlights

  • Senti Biosciences (NASDAQ:SNTI) fell 15.49% on October 16, at an indicated pre-market price of USD 0.2210, at an indicated price of USD 0.2210, at an indicated price of USD 0.2210, at an indicated price of USD 0.2210.
  • Autolus Therapeutics (NASDAQ:AUTL) fell 10.92% on October 16, at an indicated pre-market price of USD 1.53, at an indicated price of USD 1.53, at an indicated price of USD 1.53, at an indicated price of USD 1.53.
  • Scinai Immunotherapeutics (NASDAQ:SCNI) fell 7.15% on October 16, at an indicated pre-market price of USD 0.8370, at an indicated price of USD 0.8370, at an indicated price of USD 0.8370, at an indicated price of USD 0.8370.
  • Estrella Immunopharma (NASDAQ:ESLA) fell 5.77% on October 16, at an indicated pre-market price of USD 0.5043, at an indicated price of USD 0.5043, at an indicated price of USD 0.5043, at an indicated price of USD 0.5043.

Senti Biosciences (NASDAQ:SNTI): Pre-Market Move

Senti Biosciences (NASDAQ:SNTI) was indicated down 15.49% at USD 0.2210 in pre-market trading on October 16. Senti Biosciences, a cell therapy company, was indicated down 15.49% at USD 0.2210 pre-market on October 16, implying a prior close near USD 0.2615, with no company-specific disclosure dated October 15 or 16 identified in filings or newswire coverage. Index-level pre-market trading on October 16 was calm, with S&P 500 and Nasdaq-100 exchange-traded funds up about 0.25% and 0.19% ahead of bank and insurer earnings from Travelers, Truist and M&T Bank, while micro-cap names with thin pre-market liquidity moved sharply on little information. A USD 0.01 change on a USD 0.2210 price equals about 4.5%, so tick size and thin pre-market liquidity magnify percentage moves in low-priced shares. The move therefore appears to reflect sector sentiment and trading flows rather than a reported event, and it may reverse at the open. The indicated price of USD 0.2210 compares with an implied prior close of about USD 0.2615, a move of about USD 0.0405 a share. The indicated price of USD 0.2210 compares with an implied prior close near USD 0.2615, a move of about USD 0.0405 a share. A one-cent move on a USD 0.22 stock equals about 4.5%, so tick size magnifies percentage changes. The price is below USD 1.00, the Nasdaq minimum bid threshold, which exposes the company to compliance notices, reverse splits and dilution. Thin pre-market liquidity, tiny market values and financing or listing pressures can reverse indicated moves quickly at the open. By size of pre-market move it ranks 1 of 5 in this group. What to watch next: company filings, financing and regular-session volume.

Autolus Therapeutics (NASDAQ:AUTL): Pre-Market Move

Autolus Therapeutics (NASDAQ:AUTL) was indicated down 10.92% at USD 1.53 in pre-market trading on October 16. Autolus Therapeutics, a CAR-T cell therapy company, was indicated down 10.92% at USD 1.53 pre-market on October 16, implying a prior close near USD 1.7176, with no company-specific disclosure dated October 15 or 16 identified in filings or newswire coverage. A USD 0.01 change on a USD 1.53 price equals about 0.7%, so tick size and thin pre-market liquidity magnify percentage moves in low-priced shares. The indicated price of USD 1.53 compares with an implied prior close of about USD 1.7176, a move of about USD 0.1876 a share. The indicated price of USD 1.5300 compares with an implied prior close near USD 1.7176, a move of about USD 0.1876 a share. A one-cent move on a USD 1.53 stock equals about 0.7%, so tick size magnifies percentage changes. The price is above the USD 1.00 Nasdaq minimum bid threshold, though liquidity remains thin in pre-market trading. By size of pre-market move it ranks 2 of 5 in this group.

Scinai Immunotherapeutics (NASDAQ:SCNI): Pre-Market Move

Scinai Immunotherapeutics (NASDAQ:SCNI) was indicated down 7.15% at USD 0.8370 in pre-market trading on October 16. Scinai Immunotherapeutics, a biopharmaceutical and contract manufacturing company, was indicated down 7.15% at USD 0.8370 pre-market on October 16, implying a prior close near USD 0.9015, with no company-specific disclosure dated October 15 or 16 identified in filings or newswire coverage. A USD 0.01 change on a USD 0.8370 price equals about 1.2%, so tick size and thin pre-market liquidity magnify percentage moves in low-priced shares. The indicated price of USD 0.8370 compares with an implied prior close of about USD 0.9015, a move of about USD 0.0645 a share. The indicated price of USD 0.8370 compares with an implied prior close near USD 0.9015, a move of about USD 0.0645 a share. A one-cent move on a USD 0.84 stock equals about 1.2%, so tick size magnifies percentage changes. By size of pre-market move it ranks 4 of 5 in this group.

Estrella Immunopharma (NASDAQ:ESLA): Pre-Market Move

Estrella Immunopharma (NASDAQ:ESLA) was indicated down 5.77% at USD 0.5043 in pre-market trading on October 16. Estrella Immunopharma, a T-cell therapy company, was indicated down 5.77% at USD 0.5043 pre-market on October 16, implying a prior close near USD 0.5352, with no company-specific disclosure dated October 15 or 16 identified in filings or newswire coverage. A USD 0.01 change on a USD 0.5043 price equals about 2.0%, so tick size and thin pre-market liquidity magnify percentage moves in low-priced shares. The indicated price of USD 0.5043 compares with an implied prior close of about USD 0.5352, a move of about USD 0.0309 a share. The indicated price of USD 0.5043 compares with an implied prior close near USD 0.5352, a move of about USD 0.0309 a share. A one-cent move on a USD 0.50 stock equals about 2.0%, so tick size magnifies percentage changes. By size of pre-market move it ranks 5 of 5 in this group.

Shuttle Pharmaceuticals (NASDAQ:SHPH): Pre-Market Move

Shuttle Pharmaceuticals (NASDAQ:SHPH) was indicated down 7.90% at USD 5.13 in pre-market trading on October 16. Shuttle Pharmaceuticals, a clinical-stage radiation oncology company, was indicated down 7.90% at USD 5.13 pre-market on October 16, implying a prior close near USD 5.5700, with no company-specific disclosure dated October 15 or 16 identified in filings or newswire coverage. Thin pre-market liquidity means indicated prices can differ materially from the regular-session open. The indicated price of USD 5.13 compares with an implied prior close of about USD 5.5700, a move of about USD 0.4400 a share. The indicated price of USD 5.1300 compares with an implied prior close near USD 5.5700, a move of about USD 0.4400 a share. At USD 5.13 a one-cent move equals 0.19%, so the percentage change reflects a genuine price gap. By size of pre-market move it ranks 3 of 5 in this group.

Where Things Stand

The group of 5 pre-market movers shows how thin liquidity and tiny market values produce large percentage swings, so each name needs its own catalyst check. Senti Biosciences (NASDAQ:SNTI) fell 15.49%. Autolus Therapeutics (NASDAQ:AUTL) fell 10.92%. Scinai Immunotherapeutics (NASDAQ:SCNI) fell 7.15%. Estrella Immunopharma (NASDAQ:ESLA) fell 5.77%. Shuttle Pharmaceuticals (NASDAQ:SHPH) fell 7.90%. Moves on stocks this small often reverse, so the balance of evidence favors waiting for filings and the next session. Direction remains unknown, and each name carries its own risks. Check each company's filings for the drivers behind the move, verify the latest filings before acting, and treat the figures as a snapshot.